These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 28987055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 8. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J, Zhang G, Zhao Z, Chan P, Ye Z.
    Brain Behav; 2024 Jul; 14(7):e3606. PubMed ID: 38945805
    [Abstract] [Full Text] [Related]

  • 9. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A, Nicoletti A, Donzuso G, Terravecchia C, Cicero CE, D'Agate C, Rascuná C, Manna R, Mostile G, Zappia M.
    J Alzheimers Dis; 2021 Jul; 80(4):1669-1674. PubMed ID: 33720901
    [Abstract] [Full Text] [Related]

  • 10. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L, Bonaccorsi J, Del Prete E, Cintoli S, Pagni C, Mazzucchi S, Palermo G, Morganti R, Frosini D, Siciliano G, Tognoni G, Ceravolo R.
    Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
    [Abstract] [Full Text] [Related]

  • 11. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 12. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S, Redaelli V, Soliveri P, Fetoni V, Barocco F, Caffarra P, Scaglioni A, Tramacere I, Girotti F.
    Cortex; 2018 Dec; 109():272-278. PubMed ID: 30399478
    [Abstract] [Full Text] [Related]

  • 13. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD.
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
    Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, Girotti F.
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M, Seppi K, Mueller C, Potrusil T, Goebel G, Reiter E, Nocker M, Steiger R, Wildauer M, Gizewski ER, Wenning GK, Poewe W, Scherfler C.
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [Abstract] [Full Text] [Related]

  • 16. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ, Konkel A, Dąbrowska M, Sławek J.
    Neurol Neurochir Pol; 2015 Apr; 49(1):36-40. PubMed ID: 25666771
    [Abstract] [Full Text] [Related]

  • 17. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L, Fuchs A, Ransmayr-Tepser S, Kommenda R, Kögl M, Schwingenschuh P, Fellner F, Guger M, Eggers C, Darkow R, Mangesius S, Ransmayr G.
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [Abstract] [Full Text] [Related]

  • 18. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A, Pagonabarraga J, Martínez-Horta S, Busteed L, Pascual-Sedano B, Illán-Gala I, Marin-Lahoz J, Aracil-Bolaños I, Pérez-Pérez J, Sampedro F, Bejr-Kasem H, Kulisevsky J.
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [Abstract] [Full Text] [Related]

  • 19. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS, Sedlacik J, Boelmans K, Forkert ND.
    Neuroimage Clin; 2018 Sep; 20():1037-1043. PubMed ID: 30342392
    [Abstract] [Full Text] [Related]

  • 20. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M, Diehl-Schmid J, Hapfelmeier A, Kontaxopoulou D, Stefanis L, Oertel WH, Bhatia KP, Papageorgiou SG, Höglinger GU.
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.